by David Kent | Aug 22, 2023
As an academic researcher in the blood stem cell field for the last 20 years, I’ve been involved in a large number of interdisciplinary collaborations and, more recently, a series of industry partnerships. There is no doubt in my mind that cell and gene therapy is one...
by Don Gibbons | May 25, 2023
A recent Wall Street Journal article reminded me of the work of someone I came to know well while at the California Institute for Regenerative Medicine (CIRM): Jeanne Loring of the Scripps Research Institute. The article detailed a cell therapy for Parkinson’s Disease...
by Stacey Johnson | Oct 4, 2019
One of the speakers invited to the Current Trends in Biotherapeutics Workshop, hosted by the Clinical Translation Education Group (CTEG),* was Alexandre Le Bouthillier, co-founder of Imagia. This Montreal-based company is harnessing the power of artificial...
by Jovana Drinjakovic | Sep 27, 2017
The potential of lab-grown mini organs goes beyond learning how to manufacture replacement body parts to undo disease; it could allow researchers to glimpse, for the first time, the swaths of microorganisms that live inside us and shape our health. A deeply entrenched...
Comments